Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012

Journal of Hypertension

Volumn 34, Issue 6, 2016, Pages 1208-1217

  Sengul, Sule ^a   Akpolat, Tekin ^b   Erdem, Yunus ^c   Derici, Ulver ^d   Arici, Mustafa ^c   Sindel, Sukru ^d   Karatan, Oktay ^a   Turgan, Cetin ^b   Hasanoglu, Enver ^e   Caglar, Sali ^b   Erturk, Sehsuvar ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b BAHCESEHIR UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d Department of Nephrology ^*  (Turkey)

^e GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

awareness; control; hypertension; prevalence; treatment; Turkey

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; AWARENESS; CONTROL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TURKEY (REPUBLIC); URBAN AREA; ANAMNESIS; ATTITUDE TO HEALTH; BLOOD PRESSURE; BREAD; DIET; GENETICS; MIDDLE AGED; QUESTIONNAIRE; SECONDARY PREVENTION; SELF REPORT; SEX DIFFERENCE; SMOKING; TRENDS; TURKEY; URBAN POPULATION; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BREAD; DIABETES MELLITUS; DIET; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; OBESITY; PREVALENCE; SECONDARY PREVENTION; SELF REPORT; SEX FACTORS; SMOKING; SURVEYS AND QUESTIONNAIRES; TURKEY; URBAN POPULATION; YOUNG ADULT;

EID: 84961221648     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000901     Document Type: Article

References (53)

1. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
2. World Health Organization. Cardiovascular diseases in developing countries. World Health Stat Q 1993; 46:90-1599.
3. Dodu SRA. Emergence of cardiovascular diseases in developing countries. Cardiology 1988; 75:56-64.
4. Address Based Population Registration System. http://tuikapp.tuik.- gov.tr/adnksdagitapp/adnks.zul [Accessed 25 May, 2015].
5. The Ministry of Health, Department of Health Research. Turkey burden of disease study. http://ekutuphane.sagem.gov.tr/kitap.php?id=153&k=turkey-burden-of-disease-study. [Accessed 25 May 2015]
6. Turkish Statistical Institute. Causes of death statistics 2012; http:// www.turkstat.gov.tr/PreHaberBultenleri.do?id=15847. [Accessed 25 May 2015].
7. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36:839-859.
8. Sonmez HM, Basak O, Camci C, Baltaci R, Karazeybek HS, Yazgan F, et al. The epidemiology of elevated blood pressure as an estimate for hypertension in Aydin, Turkey. J Hum Hypertens 1999; 13:399-404.
9. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156:1-10.
10. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002; 25:1551-1556.
11. Onal AE, Erbil S, Ozel S, Aciksari K, Tumerdem Y. The prevalence of and risk factors for hypertension in adults living in Istanbul. Blood Press 2004; 13:31-36.
12. Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf) 2009; 31:47-58.
13. Sariisik A, Oguz A, Uzunlulu M. Control of hypertension in Turkey-is it improving? The Kocaeli 2 study. Turk Kardiyol Dern Ars 2009; 37 (Suppl 6):13-16.
14. Suleymanlar G, Utas C, Arinsoy T, Ates K, Altun B, Altiparmak MR, et al. A population-based survey of Chronic REnal Disease in Turkey: the CREDIT study. Nephrol Dial Transplant 2011; 26:1862-1871.
15. Dogan N, Toprak D, Demir S. Hypertension prevalence and risk factors among adult population in Afyonkarahisar region: a cross-sectional research. Anadolu Kardiyol Derg 2012; 12:47-52.
16. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28:169-180.
17. Altun B, Arici M, Nergizoglu G, Derici U, Karatan O, Turgan C, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in. J Hypertens 2005; 23:1817-1823.
18. Ministry of Health. Health Transformation Program, Ankara, Turkey 2003; http://www.saglik.gov.tr/TR/belge/1-2906/saglikta-donusumprogrami.html. [Accessed 25 May 2015].
19. Atun R, Aydin S, Chakraborty S, Sumer S, Aran M, Gurol I, et al. Universal health coverage in Turkey: enhancement of equity. Lancet 2013; 382:65-99.
20. World Health Organization. Report of a WHO consultation on obesity. Geneva: WHO Press; 1997.
21. Briasoulis A, Agarwal V, Messerli FH. Alcohol consumption and the risk of hypertension in men and women: a systematic review and metaanalysis. J Clin Hypertens (Greenwich) 2012; 14:792-798.
22. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
23. Basu S, Millett C. Social epidemiology of hypertension in middleincome countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension 2013; 62:18-26.
24. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet 2012; 380:611-619.
25. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27:963-975.
26. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2013 update: a report from the American heart association. Circulation 2013; 127:143-152.
27. Akgun S, Rao C, Yardim N, Basara BB, Aydin O, Mollahaliloglu S, Lopez AD. Estimating mortality and causes of death in Turkey: methods, results and policy implications. Eur J Public Health 2007; 17:593-599.
28. Erdem Y, Arici M, Altun B, Turgan C, Sindel S, Erbay B, et al. The relationship between hypertension and salt intake in Turkish population: SALTURK study. Blood Press 2010; 19:313-318.
29. Akpolat T, Kadi R, Utas C. Hypertension, salt, and bread. Am J Kidney Dis 2009; 53:1103.
30. Maziak W, Rastam S, Mzayek F, Ward KD, Eissenberg T, Keil U. Cardiovascular health among adults in Syria: a model from developing countries. Ann Epidemiol 2007; 17:713-720.
31. Saeed AA, Al-Hamdan NA, Bahnassy AA, Abdalla AM, Abbas MA, Abuzaid LZ. Prevalence, awareness, treatment, and control of hypertension among Saudi adult population: a national survey. Int J Hypertens 2011; 2011:174135.
32. Llisterri JL, Rodriguez-Roca GC, Escobar C, Alonso-Moreno FJ, Prieto MA, Barrios V, et al. Treatment and blood pressure control in Spain during. J Hypertens 2012; 30:2425-2431.
33. Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A, et al. Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens 2012; 30:1065-1074.
34. Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, Carmona J. Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. J Hypertens 2005; 23:1661-1666.
35. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 2012; 60:599-606.
36. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011; 183:1007-1013.
37. Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the health survey for England. Hypertension 2009; 53:480-486.
38. Kronborg CN, Hallas J, Jacobsen IA. Prevalence, awareness, and control of arterial hypertension in Denmark. J Am Soc Hypertens 2009; 3:19-24.
39. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10:1097-1102.
40. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States. JAMA 2003; 290:199-206.
41. Polonia J, Martins L, Pinto F, Nazare J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study. J Hypertens 2014; 32:1211-1221.
42. Meng XJ, Dong GH, Wang D, Liu MM, Lin Q, Tian S, et al. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. J Hypertens 2011; 29:1303-1310.
43. Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. J Hypertens 2001; 19:1523-1532.
44. Gupta R, Deedwania PC, Achari V, Bhansali A, Gupta BK, Gupta A, et al. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens 2013; 26:83-94.
45. Wagner A, Sadoun A, Dallongeville J, Ferrieres J, Amouyel P, Ruidavets JB, Arveiler D. High blood pressure prevalence and control in a middleaged French population and their associated factors: the MONA LISA study. J Hypertens 2011; 29:43-50.
46. Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in Mozambique: urban/rural gap during epidemiological transition. Hypertension 2009; 54:77-83.
47. Gee ME, Bienek A, McAlister FA, Robitaille C, Joffres M, Tremblay MS, et al. Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension. Can J Cardiol 2012; 28:375-382.
48. Siven SS, Niiranen TJ, Aromaa A, Koskinen S, Jula AM. Social, lifestyle and demographic inequalities in hypertension care. Scand J Public Health 2015; 43:246-253.
49. Lloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S. Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. Int J Epidemiol 2014; 43:116-128.
50. RahmanMM, Gilmour S, Akter S, Abe SK, Saito E, Shibuya K. Prevalence and control of hypertension in Bangladesh: a multilevel analysis of a nationwide population-based survey. J Hypertens 2015; 33:465-472.
51. MalekzadehMM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens 2013; 31:1364-1371.
52. Agyemang C, van Valkengoed I, Koopmans R, Stronks K. Factors associated with hypertension awareness, treatment and control among ethnic groups in Amsterdam, the Netherlands: the SUNSET study. J Hum Hypertens 2006; 20:874-881.
53. Guessous I, Bochud M, Theler JM, Gaspoz JM, Pechere-Bertschi A. 2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS One 2012; 7:e39877.